logo-loader
viewNuminus Wellness

Numinus Wellness lists on TSX, strengthens its medical expertise team with a focus on psychedelics

Numinus Wellness Inc. (TSX-V: NUMI) CEO Payton Nyquvest tells Proactive the psychedelics health care company is strengthening its medical expertise team with the appointment of Dr. Gabor Maté, as a Member of the Numinus Clinical Advisory Council and Dr. Evan Wood as Chief Medical Officer.

Nyquvest says the Vancouver-based firm, which recently listed on the Toronto Stock Exchange, has a license through Health Canada to test, possess, buy and sell MDMA, psilocybin, psilocin, and DMT. It hopes to scale its model of operating stand-alone centers for patients with its health solutions in future acquisitions.

Quick facts: Numinus Wellness

Price: 0.375 CAD

TSX-V:NUMI
Market: TSX-V
Market Cap: $35.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

iCoreConnect cloud-based software is a real game changer in healthcare

iCoreConnect (OTCQB: ICCT) President and CEO Robert McDermott joined Steve Darling from Proactive to discuss the company that provides HIPAA-compliant software for the medical and dental industries. McDermott discusses a few of their services, their recent revenue growth and why listing on...

14 hours, 32 minutes ago

2 min read